Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Dolutegravir/Lamivudine/Tenofovir Mylan


Contraindicated
Safety has not been established

Contraindicated
Dolutegravir/Lamivudine/Tenofovir Mylan :
Type Medicine Authorised
Originator G
Agent Mediterranean Pharmaceutical Company
Distributor Mediterranean Pharmaceutical Company
Laboratory Mylan
Responsible Party Mylan Laboratories Ltd
Origin India
Manufacturer Mylan Laboratories Ltd
Manufacturing Type G
Origin India
ATC J05AR27

Your comment will appear shortly after approval

Different Units By MoH Code

Dolutegravir/Lamivudine/Tenofovir Mylan  MoH 11410 :
Form Tablet
Package Size Box of 30
Strength 300mg/50mg/300mg
Storage Condition <30°C Away from moisture
Public Price 54836160.44 L.L.
Stratum E1
NSSF ✘
Quarantine ✘
Reg. Number 177119/1
Submission date 21/11/2019
Registration Year 05/12/2023
Pending Year 02/12/2020
Pending Reason Incomplete file


Price Comparison

● Country: Lebanon
● Form: Tablet
● Package Size: Box of 30
● Public Price: 54836160.44 LBP ( 54,836,160.44 LBP )
● Pack size unit used: 30
● Cost/Unit: 1827872,01 LBP ( 1,827,872.00 LBP )
● Pricing Date: 13/06/2024

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info